Pediatr. praxi. 2007;8(5):292-298

The antibiotic use in primary pediatric care

doc. MUDr. Vilma Marešová CSc
I. infekční klinika 2. LF a Katedra infekčních nemocí IPVZ, Praha

The problem of antibiotic resistance in the Czech Republic has touched to various extent all bacterial agents of invasive and local infections in hospitals and communities. The improvement in quality of antibiotic use and decrease of antibiotic use by limitation of its prescription in cases not considered being effective and responsible approach to prescription could decrease growing trends of antibiotic resistance of bacteria in community with preservation of efficacy of old and new medications. The highest consumption of antibiotics is in respiratory infections followed by urinary tract infections and skin infections. The knowledge of indications and correct antibiotic practice enables to solve the problem and preserve antibiotics even for future.

Keywords: antibiotics, antibiotic resistance, drug of choise, alternative drugs

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marešová V. The antibiotic use in primary pediatric care. Pediatr. praxi. 2007;8(5):292-298.
Download citation

References

  1. Bartoníčková K, Bébrová E, Beneš J, Čížek J, Dostál V, Galský J, Horáčková M, Chmelík V, Jindrák V, Karen I, Kolář M, Kolská M, Kolský A, Marek J, Marešová V, Matoušková M, Nýč O, Urbášková P. Doporučený postup pro antibiotickou léčbu komunitních infekcí ledvin a močových cest v primární péči. Praktický lékař. 2006; 86(8): 429-438 (www.cls.cz/dp/2006/dpimc.doc).
  2. Blechová Z. Časté komunitní infekce dětského věku a jejich léčba. Pediatr. pro Praxi. 2005; 6(2): 71-75.
  3. Cunha BA. Penicillin resistance in pneumococcal pneumonia. Postgrad. Med. 2003; 113(1): 42-54. Go to original source... Go to PubMed...
  4. Čižman M, Pokorn M, Seme K et al. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrobial. Chemother. 2001; 47: 475-477. Go to original source... Go to PubMed...
  5. Hoza J, Jindrák V, Marešová V, Nyč O, Sechser T, Suchopár J, Švihovec J, Urbášková P. Konsensus používání antibiotik I. Penicilinová antibiotika, Praktický lékař 2002; 82(5): 251-261 (www. cls.cz).
  6. Jindrák V, Bébrová E. Mikrobiologické podklady pro léčbu antibiotiky v ambulantní praxi. Klin. mikrob. inf. lék. 2000; 6(9-10): 290-293.
  7. Jindrák V, Henyšová J, Vaniš V, Urbášková P, Litoš P. Rezistence Streptococcus pyogenes k erytromycinu jako regionální problém. Klin. mikrobiol. inf. lék., 1999;5: 237-243.
  8. Marešová V. Clarithromycin. Remedia 1995; 5(4): 184-191.
  9. Marešová V, Urbášková P. Phnenoxymethylpenicillinum (penicilin V). Remedia 2005; 15(3): 221-226.
  10. Marešová V. Spiramycin. Remedia. Remedia. 2006; 16(1): 37-45.
  11. Marešová V. Doxycyklin. Remedia 1996; 6(5): 27-283. Go to original source...
  12. Micromedex (databáze léků). 1/2006-02-05.
  13. Nelson JD, Bradley JS. Nelson's Pocket Book of Pediatric Antimicrobial Therapy. Lippincott Williams&Wilkins, USA, 2006.
  14. Příborský J. Makrolidy. Maxdorf Praha, 2001.
  15. Příborský J. Cefalosporiny. Maxdorf Praha 1999.
  16. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England J. Med. 1997; 337: 441-446. Go to original source... Go to PubMed...
  17. Štika, L. Spotřeba antimikrobiálních léčiv a její vliv na rezistenci mikroorganizmů. Klin. mikrobiol. inf. lék., 2001; 10: 66-71.
  18. Urbášková P. Trendy rezistence na antibiotika u některých původců komunitních infekcí v ČR. Pediatr. pro Praxi 2000; 1(3): 105-107.
  19. Urbášková P, Jakubů V, Žemličková H a účastníci CZ-EARSS. EARSS v České republice: Surveillance antibiotické rezistence invazivních izolátů Streptococcus pneumoniae, Staphylococcus aureus, E. coli, Enterococcus faecalis a E. faecium. Zprávy Centra epidemiologie a mikrobiologie, 2001; 10: 310-315. (http://www.szu.cz/cem/zprávy/default.htm)
  20. Urbášková P, Jindrák V, Marešová V. Antibiotická rezistence u hlavních původců bakteriálních infekcí v ČR. Lege Artis. 2001; 1(9): 5-7.
  21. Urbášková P, Marešová V, Jindrák V, Nyč O, Suchopár J, Sechser T, Hoza J, Karen I, Švihovec J. Konsenzus používání antibiotik II. Makrolidová antibiotika. Prakt. Lék. 2003; 83(10): 563-571(www. cls.cz/dp/2003/ATB). Go to original source...
  22. WHO Model Prescribing Information: Drugs used in bacterial infections. WHO Geneva, 2001.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.